Our Mission

TRiCares’ mission is to revolutionize the treatment of tricuspid regurgitation (TR). We are developing Topaz, a minimally invasive tricuspid valve replacement system designed to eliminate TR and improve patient outcomes. Our goal is for Topaz to become the valve of choice for TR treatment, offering a safe and effective solution that overcomes limitations of existing approaches. 

TRiCares Team

We are a growing team, with diverse skills and experiences, who share the vision of bringing the highest-quality tricuspid regurgitation treatment to market.

Management

Ahmed
Elmouelhi

President and CEO

Ahmed
Elmouelhi

President and CEO

  • Over 20 years of experience in the medical device industry, covering strategy, sales & marketing, R&D and clinical science
  • Served as Senior Vice President of Product Marketing, Strategy and Business Development at AtriCure
  • Held major roles at Medtronic, within its Structural Heart division, and at AGA Medical (now part of Abbott Laboratories)
     

Esther
Gerteis

VP Medical & Regulatory Affairs

Esther
Gerteis

VP Medical & Regulatory Affairs

  • Over 20 years of experience in clinical research with Edwards Lifesciences, Biotronik VI and CorFlow Therapeutics
  • Specialized in interventional cardiology, surgical and transcatheter heart valve therapy, heart failure and vascular intervention across Europe, US and Asia
     

Laura
Ghione

Chief Operating Officer

Laura
Ghione

Chief Operating Officer

  • 20 years of experience in heart valves design, development and operations management 
  • Former Heart Valve R&D Senior Director at Sorin/LivaNova
  • Led the development of the first sutureless valve for the European market and US clearance
     

Lubos
Cechvala

Senior Director of Finance

Lubos
Cechvala

Senior Director of Finance

  • 8 years of experience in Finance and Investments in startups as well as MNCs
  • Experienced in fundraising, investor relations, controlling, accounting, contracting as well as public grants

Michael
Litzenburger

VP R&D

Michael
Litzenburger

VP R&D

  • Over 15 years structural heart experience, specific in novel technologies for Aortic, Mitral and Tricuspid valve repair and replacement
  • Member of Task force to build an R&D Team for TAVR in the USA
  • Held a key role in the R&D Team of his previous company to run successfully through FIM and CE study of a TAVR System.

Scientific Advisory Board

  • Philipp Blanke, MD, Director Cardiac CT Core Laboratory, St Paul’s Hospital & University of British Columbia, Vancouver, British Columbia, Canada
  • Julien Dreyfus, MD, PhD, FESC, Cardiologist, Centre Cardiologique du Nord, St. Denis, France
  • Neil Fam, MD, Director Structural Heart Program at St. Michael’s Hospital and the Schroeder Chair in Structural and Valve Innovation, University of Toronto, Canada
  • Santiago Garcia, MD, Director Structural Heart Program and Schott Endowed Chair for Structural Heart, The Carl and Edyth Lindner Center for Research and Education and The Christ Hospital, Cincinnati, Ohio, USA
  • Eberhard Grube, MD, MSCAI, Professor of Medicine, Head, Center of Innovative Interventions in Cardiology (CIIC) University Hospital Bonn, Germany
  • Jörg Hausleiter, MD, Deputy Director Medical Clinic and Polyclinic I, University Hospital Munich, Germany
  • Susheel Kodali MD, Director Structural Heart and Valve Center at Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, USA
  • Pascal Lim, MD, Cardiologist, University Hospital Henri Mondor, Créteil, France
  • Mohammed Nejjari, MD, Interventional Cardiologist, Centre Cardiologique du Nord, St. Denis, France
  • Ulrich Schäfer, MD, Director Department Innovative Interventional Cardiology, Heart and Vascular Center Bad Bevensen, Germany
  • Vinod Thourani, MD, Chief Department of Cardiovascular Surgery, Director Structural Heart Center of Excellence, Marcus Heart Valve Center, Piedmont Hospital, Atlanta, Georgia, USA
  • Hendrik Treede, MD, Director Department Cardiac and Vascular Surgery, University Hospital Mainz, Germany
  • Pradeep Yadav, MD, Interventional Cardiologist, Structural Heart Disease - Interventional Cardiology, Marcus Heart Valve Center, Piedmont Hospital, Atlanta, Georgia, USA